Year |
Citation |
Score |
2017 |
Yang Y, Haeger SM, Suflita MA, Zhang F, Dailey KL, Colbert JF, Ford JA, Picon MA, Stearman RS, Lin L, Liu X, Han X, Linhardt RJ, Schmidt EP. Fibroblast Growth Factor Signaling Mediates Pulmonary Endothelial Glycocalyx Reconstitution. American Journal of Respiratory Cell and Molecular Biology. PMID 28187268 DOI: 10.1165/Rcmb.2016-0338Oc |
0.659 |
|
2016 |
Schultz V, Suflita M, Liu X, Zhang X, Yu Y, Li L, Green DE, Xu Y, Zhang F, DeAngelis PL, Liu J, Linhardt RJ. Heparan sulfate domains required for fibroblast growth factor 1 and 2 signaling through fibroblast growth factor receptor 1c. The Journal of Biological Chemistry. PMID 28031461 DOI: 10.1074/Jbc.M116.761585 |
0.689 |
|
2016 |
Schmidt EP, Overdier KH, Sun X, Lin L, Liu X, Yang Y, Ammons LA, Hiller TD, Suflita MA, Yu Y, Chen Y, Zhang F, Cothren Burlew C, Edelstein CL, Douglas IS, et al. Urinary Glycosaminoglycans Predict Outcomes in Septic Shock and ARDS. American Journal of Respiratory and Critical Care Medicine. PMID 26926297 DOI: 10.1164/Rccm.201511-2281Oc |
0.651 |
|
2015 |
Fu L, Suflita M, Linhardt RJ. Bioengineered heparins and heparan sulfates. Advanced Drug Delivery Reviews. PMID 26555370 DOI: 10.1016/J.Addr.2015.11.002 |
0.509 |
|
2015 |
Suflita M, Fu L, He W, Koffas M, Linhardt RJ. Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering. Applied Microbiology and Biotechnology. 99: 7465-79. PMID 26219501 DOI: 10.1007/S00253-015-6821-9 |
0.602 |
|
2015 |
Bhaskar U, Li G, Fu L, Onishi A, Suflita M, Dordick JS, Linhardt RJ. Combinatorial one-pot chemoenzymatic synthesis of heparin. Carbohydrate Polymers. 122: 399-407. PMID 25817684 DOI: 10.1016/J.Carbpol.2014.10.054 |
0.66 |
|
2015 |
Zhang J, Suflita M, Li G, Zhong W, Li L, Dordick JS, Linhardt RJ, Zhang F. High cell density cultivation of recombinant Escherichia coli strains expressing 2-O-sulfotransferase and C5-epimerase for the production of bioengineered heparin. Applied Biochemistry and Biotechnology. 175: 2986-95. PMID 25586487 DOI: 10.1007/S12010-014-1466-1 |
0.686 |
|
2015 |
Zhang J, Suflita M, Fiaschetti CM, Li G, Li L, Zhang F, Dordick JS, Linhardt RJ. High cell density cultivation of a recombinant Escherichia coli strain expressing a 6-O-sulfotransferase for the production of bioengineered heparin. Journal of Applied Microbiology. 118: 92-8. PMID 25362996 DOI: 10.1111/Jam.12684 |
0.676 |
|
2014 |
Cai C, Dickinson DM, Li L, Masuko S, Suflita M, Schultz V, Nelson SD, Bhaskar U, Liu J, Linhardt RJ. Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides. Organic Letters. 16: 2240-3. PMID 24697306 DOI: 10.1021/Ol500738G |
0.631 |
|
Low-probability matches (unlikely to be authored by this person) |
2011 |
Stevenson BS, Suflita MT, Stamps BW, Moore ER, Johnson CN, Lawson PA. Hoeflea anabaenae sp. nov., an epiphytic symbiont that attaches to the heterocysts of a strain of Anabaena. International Journal of Systematic and Evolutionary Microbiology. 61: 2439-44. PMID 21075905 DOI: 10.1099/Ijs.0.025353-0 |
0.129 |
|
2013 |
Suflita MT, Pfaltzgraff ER, Mundell NA, Pevny LH, Labosky PA. Ground-state transcriptional requirements for skin-derived precursors. Stem Cells and Development. 22: 1779-88. PMID 23316968 DOI: 10.1089/Scd.2012.0501 |
0.089 |
|
2014 |
Plank JL, Suflita MT, Galindo CL, Labosky PA. Transcriptional targets of Foxd3 in murine ES cells. Stem Cell Research. 12: 233-40. PMID 24270162 DOI: 10.1016/J.Scr.2013.10.008 |
0.087 |
|
Hide low-probability matches. |